Skip to main content
. 2021 Aug 3;106(12):3455–3463. doi: 10.1210/clinem/dgab575

Figure 2.

Figure 2.

Electrochemiluminescence (ECL)–zinc transporter 8 autoantibody (ZnT8A) and radiobinding assay (RBA)-ZnT8A in the Autoimmunity Screening for Kids study. A, Comparison of cumulative incidence (%) of clinical type 1 diabetes (T1D) (stage 3 T1D) in 2 groups: RBA + ECL + and RBA + ECL–. Solid line: individuals with RBA-ZnT8A confirmed by ECL, dotted line: individuals with RBA-ZnT8A not confirmed by ECL. B, Positive predictive values (PPV) of stage 1 to stage 3 T1D in individuals with ECL-ZnT8A or RBA-ZnT8A.